Teladoc Health (TDOC) Receivables - Other (2014 - 2026)

Teladoc Health has disclosed Receivables - Other across 7 years of filings, most recently posting $8.9 million for Q1 2026.

• Receivables - Other for Q1 2026 came in at $8.9 million, down 13.17% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.9 million (down 13.17% YoY), and the FY2025 annual result was $8.8 million, down 9.94% from the prior year.
• Receivables - Other came in at $8.9 million for Q1 2026 at Teladoc Health, up from $8.8 million in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $25.1 million in Q1 2023 to a low of $8.6 million in Q2 2025.
• The 5-year median for Receivables - Other is $12.3 million (2023), against an average of $14.6 million.
• Across the five-year window, Receivables - Other advanced 18.53% in 2022 and tumbled 49.62% in 2023, its largest moves.
• Teladoc Health's Receivables - Other stood at $25.1 million in 2022, then sank by 49.62% to $12.6 million in 2023, then slipped by 22.4% to $9.8 million in 2024, then slipped by 9.94% to $8.8 million in 2025, then rose by 0.87% to $8.9 million in 2026.
• The last three Receivables - Other figures came in at $8.9 million (Q1 2026), $8.8 million (Q4 2025), and $8.7 million (Q3 2025), per Business Quant data.